Latest Headlines

31. Vetter Aligns Its Development Service Laboratory Portfolio Under One Roof 1/30/2020

    Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) has brought together its development laboratories in one Ravensburg site end of last year

32. OGT Launches Breakthrough CytoSure NGS Panel For Constitutional Cytogenetics 1/30/2020

    Oxford Gene Technology (OGT), A Sysmex Group Company, has launched a transformative next-generation sequencing (NGS) panel for constitutional cytogenetics research

33. Novel Coronavirus: In Vitro Diagnostics Brought To Bear 1/30/2020

    The recent novel coronavirus, responsible for over 100 deaths in the Hubei province in China at the time of writing, undermines any notion of a known quantity of infectious disease threats in the world that lab analyzer menus will remain adequate, according to IVD market research Kalorama Information

34. Erba Mannheim Poised To Be Game Changer In Total Lab Automation At Medlab Middle East 2020 1/30/2020

    Erba Mannheim strengthens its portfolio of powerful and affordable solutions with a burst of new launches and a preview of their next generation NEXUS total lab automation system

35. GenScript Launches Novel Coronavirus Detection Assay 1/30/2020

    GenScript, the world's leading gene synthesis provider, today announced the commercial launch of an assay for detecting the Wuhan novel coronavirus (2019-nCoV)

36. Advancing Genomics For Pediatric Orthopaedic Diseases 1/30/2020

    With the goal of identifying advanced treatment approaches for children with genetic orthopaedic conditions, Shriners Hospitals for Children® and The Jackson Laboratory (JAX) have entered into a research affiliation agreement

37. IDbyDNA Raises $20M In Series B Financing To Continue Advancements In Infectious Disease Diagnosis And Pathogen Identification 1/29/2020

    IDbyDNA, Inc., a metagenomics technology company setting the standard for detection, identification, and interpretation of microorganisms and their role in human health, today announced the raise of $20 million in its Series B financing led by ARTIS Ventures and joined by Genesys Capital and others

38. Bluestar Genomics’ Breakthrough Study Highlights Promising Data For Multi-Cancer Detection From A Single Blood Draw 1/29/2020

    Bluestar Genomics, a company developing innovative, data-driven, epigenomic approaches to comprehensive disease analysis and diagnostics, today announced the publication of a new study demonstrating the efficacy of their 5-hydroxymethylcytosine (5hmC) signal detection technology for its use in breast, lung, pancreatic, and prostate cancer

39. Next Generation Phospholipid Removal Microplate 1/28/2020

    Porvair Sciences announce Microluteä PLR - a new benchmark product for phospholipid removal. The 96-well microplate provides effective removal (>99%) of phospholipids and proteins with higher levels of reproducibility from plasma and serum samples while maintaining maximum recovery of target analytes

40. Salimetrics Launches New Salivary Human Total Immunoglobulin G (IgG) ELISA Kit To Support Multidisciplinary Investigators In Serological Studies 1/28/2020

    Today, Salimetrics announced an addition to their trusted line of Better Salivary Assay Kits. The new Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment to cutting-edge salivary bioscience research